Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2020-02-14 Share Issue/Capital Cha…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
200214- Vervreemding van eigen aandelen.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB NV delivered shares to its personnel as part of long-term incentive plans (stock options). This activity directly relates to the company managing its own share capital through repurchases or issuances/deliveries. The specific definition that matches this activity is 'Transaction in Own Shares' (POS), which covers the company buying back or selling its own shares (share repurchase/issuance). Although it involves options being exercised, the core action reported is the disposal/delivery of treasury shares to employees.
2020-02-14 Dutch
200210- Disposal of own shares.pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled "Disposal of own shares" and details numerous transactions where UCB SA/NV disposed of its own shares OTC following stock option exercises for employees under various LTI Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document is a detailed announcement, not just a notice of publication, so RPA/RNS is less specific.
2020-02-10 English
200210 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA alienated (sold/transferred) its own shares following the exercise of options by its personnel, related to long-term variable compensation. This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee stock plans being settled. This aligns precisely with the definition of 'Transaction in Own Shares' (Code: POS). It is not a general regulatory filing (RNS) because it fits a specific category. It is not a Director's Dealing (DIRS) as it concerns employee stock option exercises rather than general insider trading reports, although there is overlap, POS is more specific for share issuance/repurchase related to compensation plans. It is not a Capital/Financing Update (CAP) as it is a transaction involving existing shares related to compensation, not a new fundraising effort.
2020-02-10 French
200210- Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB NV disposed of its own shares to personnel exercising options under various Long-Term Incentive (LTI) plans. This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee stock options/incentives. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement ('gereglementeerde informatie') detailing these transactions, not a general regulatory filing (RNS) or a report announcement (RPA).
2020-02-10 Dutch
200131- Disposal of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "Disposal of own shares" and details transactions where UCB SA/NV disposed of its own shares OTC following employee stock option exercises related to Long Term Incentive Programs. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. The appropriate classification code is POS (Transaction in Own Shares). The document length is relatively short (4994 chars) but it is a primary announcement detailing the transaction data, not just an announcement that a report is available.
2020-01-31 English
200131 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA disposed of its own shares ('aliéné des actions UCB hors bourse') following the exercise of options by personnel, specifically mentioning the dates, quantities, and prices of these transactions. This directly corresponds to the definition of a company reporting transactions involving its own shares, which maps to the 'Transaction in Own Shares' category. Code mapping: Transaction in Own Shares -> POS.
2020-01-31 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.